Clarivate patient centricity report underscores need for evolution from selling products to building relationships
Harnessing data sources and methodologies, including machine learning and artificial intelligence, can enable companies to meet patient needs in an age of targeted medicines london , march 23, 2022 /prnewswire/ -- clarivate plc (nyse: clvt), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report, walking the talk on patient centricity: an actionable and measurable model for life science companies , which provides analysis of personalized patient engagement and identifies the key pillars of patient centricity. the report explores how companies can infuse an ethos of patient centricity throughout their operations, measure effective patient centricity, ensure return on investment in patient-centered efforts and identify what a mature patient-centric organization looks like – with actionable steps that companies can take to build and strengthen their organizations.
CLVT Ratings Summary
CLVT Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission